Seventh Annual RNAi Roundtable Series

Seventh Annual RNAi Roundtable Series

We are hosting a series of online “RNAi Roundtables” at which Alnylam scientists and program leaders, as well as clinical collaborators, will review recent progress in many of our pipeline programs and platform.

Click on any of the RNAi Roundtables below to listen to the webcasts and view presentations from these events.

ALN-AGT, in Development for the Treatment of Hypertension
Tuesday, June 23, 2:30 pm ET

Early Stage RNAi Therapeutics Pipeline
Friday, July 17, 9:30 am ET

Additional RNAi Roundtables will be scheduled over the coming weeks, and will include:

Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1

Patisiran and Vutrisiran, in Development for the Treatment of ATTR Amyloidosis

Givosiran, for the Treatment of Acute Hepatic Porphyria



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.